2023 VISION Registry Data Report

At the time of diagnosis and treatment of the primary eye tumor did the patient utilize support services? How did this vary by country and region of residence? 117 responses I. The Patient Journey Personal Profile/Primary Diagnosis

The 13% of patients who responded “Yes” reported:

Country of residence:

7% Australia

7% Canada

(1 response)

(1 response)

3% Unknown

86% United States (11 responses)

The 3% of patients who responded “Unknown” reported:

US region:

73% West

9% Southeast (1 response) 9% Northeast (1 response)

100% United States (4 responses) Country of residence:

(8 responses)

9% Midwest

13% Yes

(1 response)

US region:

The 52% of patients who responded “No” reported:

50% Midwest

25% Northeast (1 response)

52% No

(2 responses)

Country of residence:

25% Southeast (1 response)

6% Australia

(4 responses) Ireland (1 response) Mexico (1 response) New Zealand (1 response) Norway (1 response)

32% Not offered

The 32% of patients who responded “Not offered” reported:

2%

2%

Country of residence:

Canada (4 responses)

Slovenia (1 response)

11%

3%

2%

86% United States (32 responses)

2%

US region:

86% United States (53 responses)

25% Southeast

28% West

(8 responses)

(9 responses) Southwest (2 responses) Midwest (3 responses)

US region:

32% Northeast

6%

21% West

17% Midwest

21% Northeast

(10 responses)

(11 responses)

(9 responses)

(11 responses)

9%

13% Southwest

28% Southeast

(7 responses)

(15 responses)

2023 VISION Registry Data Report

21

Made with FlippingBook Ebook Creator